CANCELLED - SECTION 8
section 8
on 05 Apr 2024
Last Applicant/ Owned by
840 Memorial Drive, 4th Floor
Cambridge
MA
02139
Serial Number
86982867 filed on 22nd Jul 2015
Registration Number
5297392 registered on 26th Sep 2017
Correspondent Address
Eleanor M. Yost
Eleanor M. Yost Goodwin Procter LLP
Attn: Trademark Administrator
Washington, DC 20001-4432
UNITED STATES
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
QUALITY OF SCIENCE. QUALITY OF LIFE
Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for other Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of genetic diseases and disorders; providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; dispensing of pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction
First Use Date in General
28th Feb 2015
First Use Date in Commerce
28th Feb 2015
Class [042]
Computer & Software Services & Scientific Services
Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; diagnostics services in the field of gene therapy design and delivery equipment; gene therapy design and delivery development of biochemical assays
First Use Date in General
28th Feb 2015
First Use Date in Commerce
28th Feb 2015
Mark Details
Serial Number
No 86982867
Mark Type
No Service Mark
Attorney Docket Number
No DIM-602-US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Apr 2024 | CANCELLED SEC. 8 (6-YR) |
| 26th Sep 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 26th Sep 2017 | REGISTERED-PRINCIPAL REGISTER |
| 19th Aug 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 18th Aug 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 05th Aug 2017 | STATEMENT OF USE PROCESSING COMPLETE |
| 05th Aug 2017 | DIVISIONAL PROCESSING COMPLETE |
| 04th Aug 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 14th Jul 2017 | DIVISIONAL REQUEST RECEIVED |
| 14th Jul 2017 | USE AMENDMENT FILED |